Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Hao‐Wei Teng"'
Autor:
Kun-Huei Yeh, Tsai-Sheng Yang, Tzu-Chi Hsu, William Tzu-Liang Chen, Hong-Hwa Chen, Hao-Wei Teng, Bo-Wen Lin, Feng-Che Kuan, Feng-Fan Chiang, Chi-Wei Duann, Ying-Shiuan Li, Meng-Ting Lin, Sabine Fiala-Buskies, Michel Ducreux, Jaw-Yuan Wang
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 11, Pp 2023-2031 (2021)
Background/Purpose: This analysis reports safety and effectiveness data from the Taiwanese cohort of the CORRELATE study. Methods: CORRELATE was a prospective, observational study to assess the safety and effectiveness of regorafenib for the treatmen
Externí odkaz:
https://doaj.org/article/1e54318f1fea4699b5f14328c5bd9068
Autor:
Hung-Chih Hsu, Kuo-Cheng Huang, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Huann-Sheng Wang, Shih-Ching Chang, Yuan-Tzu Lan, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Hou-Hsuan Cheng, Tsai-Sheng Yang, Chien-Chih Chen, Yee Chao, Hao-Wei Teng
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Given the unclear preference criteria for regorafenib in treating refractory metastatic colorectal cancer (mCRC), this study aimed to construct an algorithm in selecting right patients for regorafenib. This was a multicenter retrospective co
Externí odkaz:
https://doaj.org/article/94c4253e2ad34466ac4871891f1989f1
Autor:
Hong-Chieh Tsai, Han-Hsing Tsou, Chun-Chi Lin, Shao-Chen Chen, Hsiao-Wei Cheng, Tsung-Yun Liu, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Shih-Ching Chang, Hao-Wei Teng, Hsiang-Tsai Wang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Colorectal cancer (CRC) is one of the most well-known malignancies with high prevalence and poor 5-year survival. Previous studies have demonstrated that a high-fat diet (HFD) is capable of increasing the odds of developing CRC. Acrolein, an
Externí odkaz:
https://doaj.org/article/5177caa898a641d98b6a15973fb91965
Autor:
Sheng-Chieh Huang, Chun-Chi Lin, Hao-Wei Teng, Hung-Hsin Lin, Shih-Ching Chang, Yuan-Tzu Lan, Huann-Sheng Wang, Shung-Haur Yang, Wei-Shone Chen, Jeng-Kai Jiang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
This study expands the understanding of the role of target therapy in improving survival of patients with mCRC based on real-world study results. These data represent potential survival outcomes of Taiwanese patients with mCRC in clinical practice. C
Externí odkaz:
https://doaj.org/article/ee06e3c0334f40c7925839a4560ab0b4
Autor:
Hong-Hwa Chen, Tao-Wei Ke, Ching-Wen Huang, Jeng-Kae Jiang, Chou-Chen Chen, Yao-Yu Hsieh, Hao-Wei Teng, Bo-Wen Lin, Yi-Hsin Liang, Yu-Li Su, Hung-Chih Hsu, Feng-Che Kuan, Yenn-Hwei Chou, Johnson Lin, Ben-Ren Lin, Yu-Yao Chang, Jaw-Yuan Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Therapeutic options for metastatic CRC (mCRC) have changed significantly in recent years, greatly increasing the complexity of therapeutic decision-making. Although oncology guidelines have helped improve the care process, guidelines may also limit t
Externí odkaz:
https://doaj.org/article/51101c1ebda440049aea4e70c061c41a
Autor:
Shyh-Jen Wang, Wen-Sheng Huang, Chi-Mu Chuang, Chih-Hsien Chang, Te-Wei Lee, Gann Ting, Ming-Huang Chen, Peter Mu-Hsin Chang, Ta-Chung Chao, Hao-Wei Teng, Yee Chao, Yuh-Min Chen, Tzu-Ping Lin, Ya-Jen Chang, Su-Jung Chen, Yuan-Ruei Huang, Keng-Li Lan
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-13 (2019)
Abstract Background Liposomes are drug nano-carriers that are capable of targeting therapeutics to tumor sites because of enhanced permeability retention (EPR). In several preclinical studies with various tumor-bearing mice models, 188Re-liposome tha
Externí odkaz:
https://doaj.org/article/1e9dd843d53f498f91b032a8bb5e482a
Autor:
Chun-Yu Liu, Tzu-Ting Huang, Ji-Lin Chen, Pei-Yi Chu, Chia-Han Lee, Hsin-Chen Lee, Yu-Hsuan Lee, Yuan-Ya Chang, Shung-Haur Yang, Jeng-Kai Jiang, Wei-Shone Chen, Yee Chao, Hao-Wei Teng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Colorectal cancer (CRC) is a leading cause of cancer-related deaths. Because of the lack of reliable prognostic and predictive biomarkers for CRC, most patients are often diagnosed at a late stage. The tryptophan–kynurenine pathway plays a crucial
Externí odkaz:
https://doaj.org/article/b7f656342c8646f483742f1cdf2d741f
Autor:
Chun‐Yu Liu, Chia‐Chi Hsu, Tzu‐Ting Huang, Chia‐Han Lee, Ji‐Lin Chen, Shung‐Haur Yang, Jeng‐Kai Jiang, Wei‐Shone Chen, Kuan‐Der Lee, Hao‐Wei Teng
Publikováno v:
Molecular Oncology, Vol 12, Iss 10, Pp 1706-1717 (2018)
Endoplasmic reticulum (ER) stress is an adaptive response to various stress conditions and plays emerging roles in cancer. Activating transcription factor 6 (ATF6), one of the three major ER stress transducers, has been shown to contribute to chemore
Externí odkaz:
https://doaj.org/article/1010005a356949b49f7c49abb67ad80d
Autor:
Hong-Chieh Tsai, Han-Hsing Tsou, Chun-Chi Lin, Shao-Chen Chen, Hsiao-Wei Cheng, Tsung-Yun Liu, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Shih-Ching Chang, Hao-Wei Teng, Hsiang-Tsui Wang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/a984da602b3a4aacbdca25d091569ad2
Autor:
Miao-Erh Chang, Hao-Wei Teng
Publikováno v:
Journal of Cancer Research and Practice, Vol 3, Iss 1, Pp 23-27 (2016)
Hypereosinophilic syndrome (HES) has generally been defined as a peripheral blood eosinophil count greater than 1500/mm3 and may be associated with tissue damage. Imatinib is customarily used as the first-line therapy for HES with gene abnormalities,
Externí odkaz:
https://doaj.org/article/5c56af10dac84a1c957fba1e67bb041d